Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
756.56
807.45
792.41
773.00
705.30
727.45
741.17
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
756.56
807.45
792.41
773.00
705.30
727.45
741.17
Raw Material Cost
68.12
105.85
82.58
70.10
68.28
69.43
72.16
Purchase of Finished goods
122.97
117.24
146.09
104.26
95.98
133.22
118.35
(Increase) / Decrease In Stocks
-5.84
0.21
-26.26
10.28
5.99
-25.77
-4.24
Employee Cost
136.85
138.08
137.45
144.43
121.45
125.39
125.63
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
160.89
164.46
164.34
167.22
161.21
174.87
164.76
Total Expenditure (Excl Depreciation)
482.99
525.84
504.20
496.29
452.91
477.14
476.66
Operating Profit (PBDIT) excl Other Income
273.57
281.61
288.21
276.71
252.39
250.31
264.51
Other Income
2.23
0.02
2.81
2.69
7.95
4.22
4.55
Operating Profit (PBDIT)
275.80
281.63
291.02
279.40
260.34
254.53
269.06
Interest
45.62
48.82
49.55
48.68
54.28
57.17
59.47
Exceptional Items
0.00
-17.24
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
230.18
215.57
241.47
230.72
206.06
197.36
209.59
Depreciation
69.57
70.34
69.08
70.51
77.25
81.00
80.48
Profit Before Tax
159.41
145.35
172.67
161.10
128.87
116.36
129.11
Tax
-119.69
36.52
38.20
36.00
26.52
29.30
32.76
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
280.30
108.71
134.19
124.21
102.29
87.06
96.35
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
280.30
108.71
134.19
124.21
102.29
87.06
96.35
Share in Profit of Associates
-1.20
0.12
0.28
0.89
0.06
0.00
0.00
Minority Interest
-2.51
9.11
14.28
7.11
8.51
3.30
4.76
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
281.61
99.72
120.19
117.99
93.84
83.76
91.59
Equity Capital
13.85
13.61
13.62
13.62
13.62
13.61
13.61
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
3,077.54
0.00
0.00
0.00
0.00
Earnings per share (EPS)
20.33
7.33
8.82
8.66
6.89
6.15
6.73
Diluted Earnings per share
20.57
7.31
8.81
8.64
6.89
6.15
6.72
Operating Profit Margin (Excl OI)
36.36%
35.16%
36.48%
35.86%
35.92%
34.66%
35.8%
Gross Profit Margin
30.6%
26.92%
30.56%
29.9%
29.33%
27.33%
28.36%
PAT Margin
37.1%
13.59%
17.02%
16.21%
14.57%
12.06%
13.04%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 7.27% vs 28.02% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 200.10% vs 32.11% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 8.39% vs 70.04% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -15.95% vs 64.34% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of ERIS Lifescience With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
756.56
1,470.61
-714.05
-48.55%
Other Operating Income
0.00
0.00
0.00
Total Operating income
756.56
1,470.61
-714.05
-48.55%
Raw Material Cost
68.12
644.23
-576.11
-89.43%
Purchase of Finished goods
122.97
0.00
122.97
(Increase) / Decrease In Stocks
-5.84
-140.12
134.28
95.83%
Employee Cost
136.85
240.45
-103.60
-43.09%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.01
-0.01
-100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
160.89
373.93
-213.04
-56.97%
Total Expenditure (Excl Depreciation)
482.99
1,118.50
-635.51
-56.82%
Operating Profit (PBDIT) excl Other Income
273.57
352.11
-78.54
-22.31%
Other Income
2.23
8.77
-6.54
-74.57%
Operating Profit (PBDIT)
275.80
360.88
-85.08
-23.58%
Interest
45.62
32.69
12.93
39.55%
Exceptional Items
0.00
15.92
-15.92
-100.00%
Gross Profit (PBDT)
230.18
344.11
-113.93
-33.11%
Depreciation
69.57
81.75
-12.18
-14.90%
Profit Before Tax
159.41
262.36
-102.95
-39.24%
Tax
-119.69
60.79
-180.48
-296.89%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
280.30
201.57
78.73
39.06%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
280.30
201.57
78.73
39.06%
Share in Profit of Associates
-1.20
0.00
-1.20
Minority Interest
-2.51
0.00
-2.51
Other related items
0.00
0.00
0.00
Consolidated Net Profit
281.61
201.57
80.04
39.71%
Equity Capital
13.85
24.78
-10.93
-44.11%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
20.33
8.13
12.20
150.06%
Diluted Earnings per share
20.57
8.23
12.34
149.94%
Operating Profit Margin (Excl OI)
36.36%
24.16%
0.00
12.20%
Gross Profit Margin
30.60%
23.61%
0.00
6.99%
PAT Margin
37.10%
13.83%
0.00
23.27%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 756.56 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is -6.30% vs 1.90% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 7.27% vs 28.02% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 281.61 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 182.40% vs -17.03% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 200.10% vs 32.11% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 273.57 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is -2.86% vs -2.29% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 8.39% vs 70.04% in Mar 2025
Quarterly - Interest
Interest 45.62 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is -6.55% vs -1.47% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -15.95% vs 64.34% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 36.36%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
